Prolonged oral arsenic trioxide therapy and nephrolithiasis [corrected]

Leuk Lymphoma. 2007 Nov;48(11):2233-4. doi: 10.1080/10428190701625081.
No abstract available

Publication types

  • Comparative Study
  • Evaluation Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Arsenic / urine
  • Arsenic Poisoning / complications
  • Arsenic Poisoning / urine
  • Arsenic Trioxide
  • Arsenicals / administration & dosage*
  • Arsenicals / adverse effects*
  • Case-Control Studies
  • Drug Administration Schedule
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Middle Aged
  • Nephrolithiasis / chemically induced*
  • Oxides / administration & dosage*
  • Oxides / adverse effects*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Arsenic
  • Arsenic Trioxide